The combined effect of Gal-3 and LAG-3 has been found to be distinct from the combined effect of LAG-3 and MHCII, as reported in a study.[41] Tumor-specific CD8+ T cells and stromal cells within the TME constitute the primary origin of Gal-3. The gene discussed is CD8A; the disease is neoplasm.